{"product_id":"medifastinc-five-forces-analysis","title":"Medifast Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eA Must-Have Tool for Decision-Makers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eMedifast navigates a competitive wellness market where moderate buyer power, low supplier power, intense rivalry from incumbents and challengers, and a growing threat of substitutes shape margins and growth potential.\u003c\/p\u003e\n\u003cp\u003eThis brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Medifast’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommodity Ingredient Procurement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedifast sources soy protein, dairy and vitamins for OPTAVIA Fuelings; because these are common agricultural commodities, individual suppliers hold limited bargaining power and global sourcing mitigates supplier lock-in.\u003c\/p\u003e\n\u003cp\u003eStill, commodity price volatility matters: soy and dairy prices swung ~18–30% year-over-year in 2024, so without fixed-price contracts Medifast’s gross margin (reported 31.8% in FY2024) could be pressured by rising COGS.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThird Party Manufacturing Reliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedifast keeps in-house plants but uses third-party manufacturers for demand spikes and niche product lines, creating moderate supplier power since switching partners needs 6–12 month lead times and full quality audits.\u003c\/p\u003e\n\u003cp\u003eSupplier concentration mattered: by 2024 three contractors supplied ~28% of finished goods volume, and Medifast aimed to cut top-vendor share below 20% by 2025 to lower disruption risk.\u003c\/p\u003e\n\u003cp\u003eDiversification moves in 2025 included two new U.S. co-packers and a nearshoring shift raising domestic third-party capacity by ~35%, reducing single-vendor price leverage.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Medical and Telehealth Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe pivot to a medical weight-loss model raises supplier power because telehealth partners like LifeMD, which oversee GLP-1 prescriptions, control clinical access central to Medifast’s 2025 plan; LifeMD reported 2024 revenue growth of ~28% and served 300k+ telehealth visits, giving them leverage over pricing and service terms. Any disruption would cut Medifast’s ability to sell its integrated program and could reduce projected 2025 revenue growth (~20% target) materially.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Fulfillment Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eShipping giants like UPS (2024 revenue $101.3B) and FedEx ($63.8B) hold concentrated pricing power, squeezing DTC firms like Medifast which relies on carriers to ship to ~100,000 coaches and clients across North America.\u003c\/p\u003e\n\u003cp\u003eFuel costs up ~15% year-over-year in 2024 and logistics labor shortages pushed LTL rates up ~6%, directly pressuring Medifast’s gross margins with limited negotiation room.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh supplier concentration: 2–3 major carriers dominate market\u003c\/li\u003e\n\u003cli\u003eMedifast dependence: nationwide coach\/client network\u003c\/li\u003e\n\u003cli\u003eCost pressures: fuel +15% (2024), LTL rates +6%\u003c\/li\u003e\n\u003cli\u003eLow bargaining leverage: limited alternative logistics capacity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Infrastructure and Software Vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMedifast’s OPTAVIA app and proprietary coaching platform are central to client engagement and progress tracking, making software vendors strategic suppliers.\u003c\/p\u003e\n\u003cp\u003eDependence on major cloud providers and specialized developers creates tech-stack risk; Medifast reported IT and digital expenses of about $75 million in 2024, rising with personalization efforts planned for 2025.\u003c\/p\u003e\n\u003cp\u003eAs Medifast shifts to data-driven personalization in 2025, ongoing cloud, AI, and dev costs remain a sizable share of operating expenditure, increasing supplier bargaining leverage.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOPTAVIA app = core engagement tool\u003c\/li\u003e\n\u003cli\u003e2024 IT\/digital spend ≈ $75M\u003c\/li\u003e\n\u003cli\u003eCloud\/AI vendors raise supplier power\u003c\/li\u003e\n\u003cli\u003e2025 personalization boosts recurring costs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eModerate supplier power: input price swings, concentrated vendors \u0026amp; rising logistics\/IT costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSupplier power is moderate: commodity inputs (soy, dairy) give low supplier leverage but 2024 price swings of 18–30% threaten gross margin (FY2024 gross margin 31.8%). 2024 concentration: 3 contractors = ~28% volume; goal \u0026lt;20% by 2025. Logistics\/carriers (UPS $101.3B, FedEx $63.8B) and fuel +15%\/LTL +6% raise bargaining power. IT spend ~$75M (2024) increases tech vendor leverage.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e31.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoy\/dairy YoY swing\u003c\/td\u003e\n\u003ctd\u003e18–30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-3 vendors share\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFuel\/LTL change\u003c\/td\u003e\n\u003ctd\u003e+15% \/ +6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIT\/digital spend\u003c\/td\u003e\n\u003ctd\u003e$75M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eUncovers key drivers of competition, customer influence, supplier power, and substitution risks specific to Medifast, highlighting entry barriers, disruptive threats, and strategic levers that impact its pricing, margins, and market share.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eQuickly assess Medifast’s competitive dynamics with a one-sheet Porter's Five Forces view—ideal for rapid strategic decisions and investor briefs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow Switching Costs for Individual Clients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eClients in weight-loss face near-zero financial barriers to switch, giving strong bargaining power; US consumers spend ~\\$72.5B on weight-loss in 2024, so small price or perceived-value shifts move demand quickly.\u003c\/p\u003e\n\u003cp\u003eMedifast’s month-to-month and per-order model means customers can stop purchases immediately; Medifast reported 2024 net sales \\$1.1B, so churn swings materially affect revenue.\u003c\/p\u003e\n\u003cp\u003eTo retain customers Medifast must prove value via coaching and community; reported 2024 average order frequency fell 4%, so service-led retention is crucial.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfluence of Independent Coaches\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIndependent coaches at Medifast function as both customers and distributors, giving them outsized bargaining power—about 25,000 active coaches in 2024 generated roughly $830 million of net sales, so their collective leverage is material.\u003c\/p\u003e\n\u003cp\u003eIf commissions, product quality, or inventory issues push coaches away, a mass exodus could collapse the sales funnel quickly; a 10% coach attrition would roughly cut FY2024 revenue by ~8–10%.\u003c\/p\u003e\n\u003cp\u003eMedifast must prioritize coach income, training, and product reliability—investing in coach gross margin support and satisfaction metrics to protect the direct-selling model long-term.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice Sensitivity in a Competitive Wellness Market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBy late 2025, persistent inflation (CPI up 4.1% year-over-year in 2024) and a surge in low-cost generic weight-loss options have heightened price sensitivity among customers, with 62% of surveyed diet consumers citing cost as a top factor in 2025. Many compare OPTAVIA’s $300–$600 monthly structured plans to grocery-based diets costing roughly $150–$250 or digital app subscriptions at $10–$30\/month, constraining Medifast’s pricing power. A 5% price increase risks double-digit churn given industry elasticity estimates of −1.8, limiting Medifast’s ability to raise prices without significant active client loss.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAccess to Information and Social Proof\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpthe transparency of the digital age lets consumers compare medifast efficacy side effects and pricing across dozens sites instantly in us adults used online reviews for health decisions raising customer bargaining power.\u003e\n\u003cpa single viral negative review or critique can sway thousands fast direct-to-consumer revenues of make reputation risk material so rapid response matters.\u003e\n\u003cpmedifast must fund brand management and publish transparent clinical data of buyers trust peer reviews over ads so clarity reduces churn.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOnline review reach: 72% of US adults used health reviews (2024)\u003c\/li\u003e\n\u003cli\u003eRevenue at risk: $473m DTC sales (2023)\u003c\/li\u003e\n\u003cli\u003eTrust metric: 38% prefer peer reviews to ads\u003c\/li\u003e\n\u003cli\u003eAction: invest in studies, PR, rapid crisis response\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmedifast\u003e\u003c\/pa\u003e\u003c\/pthe\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSubscription Flexibility and Churn Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpcustomers now expect flexible subscriptions and easy cancellation in medifast reported subscription churn near industry averages of annualized for weight-loss programs so locking customers would cut acquisition invite scrutiny.\u003e\n\u003cpregulators since have penalized opaque auto-renewals so medifast competes on daily ux product efficacy and support rather than long contracts to keep revenue ltm was in\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003eHigh churn (~45% annualized, 2024)\u003c\/li\u003e\u003cli\u003eMembership\/LTM revenue $1.05B (2024)\u003c\/li\u003e\u003cli\u003eRegulatory risk on auto-renewals since 2022\u003c\/li\u003e\u003cli\u003eFocus: UX, product efficacy, support\u003c\/li\u003e\n\u003c\/pregulators\u003e\u003c\/pcustomers\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedifast at Risk: High Churn, Strong Customer Leverage \u0026amp; $473M DTC Exposure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCustomers hold strong bargaining power: low switching costs and price sensitivity (US weight-loss spend ~$72.5B in 2024) mean small price or value shifts move demand; Medifast’s 2024 net sales $1.1B and ~25,000 coaches (≈$830M sales) concentrate leverage. High churn (~45% annualized, 2024) and online review use (72% of US adults, 2024) limit pricing power (elasticity ≈−1.8); invest in coach retention, clinical data, and rapid PR.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (Year)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS weight-loss market\u003c\/td\u003e\n\u003ctd\u003e$72.5B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedifast net sales\u003c\/td\u003e\n\u003ctd\u003e$1.1B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eActive coaches\u003c\/td\u003e\n\u003ctd\u003e~25,000 (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCoach-driven sales\u003c\/td\u003e\n\u003ctd\u003e~$830M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDTC revenue at risk\u003c\/td\u003e\n\u003ctd\u003e$473M (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubscription churn\u003c\/td\u003e\n\u003ctd\u003e~45% annualized (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOnline health-review use\u003c\/td\u003e\n\u003ctd\u003e72% US adults (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eMedifast Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Medifast Porter’s Five Forces analysis you'll receive—no samples or placeholders, fully formatted and ready for immediate download after purchase.\u003c\/p\u003e\n\u003cp\u003eYou're viewing the complete, professionally written document; once you buy, you'll get instant access to this identical file for use in valuation, strategy, or presentation without further setup.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56746904650105,"sku":"medifastinc-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/medifastinc-five-forces-analysis.png?v=1772193073","url":"https:\/\/matrixbcg.com\/products\/medifastinc-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}